Deriv nhận Chứng nhận Vàng từ Tổ chức Investors in People 19-04-2023, 21:58

Verisk Maplecroft Named Best Specialist ESG Ratings Provider by ESG Investing 28-02-2023, 02:28

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26